반응식
CC1C=C(C)N([C:8]([CH:10]2[C:23]3[CH:22]=[CH:21][CH:20]=[CH:19][C:18]=3[O:17][C:16]3[C:11]2=[CH:12][CH:13]=[CH:14][CH:15]=3)=[O:9])N=1.[CH:24]1([C:27]2[O:31][C:30]([NH2:32])=[N:29][N:28]=2)[CH2:26][CH2:25]1>>[CH:24]1([C:27]2[O:31][C:30]([NH:32][C:8]([CH:10]3[C:23]4[CH:22]=[CH:21][CH:20]=[CH:19][C:18]=4[O:17][C:16]4[C:11]3=[CH:12][CH:13]=[CH:14][CH:15]=4)=[O:9])=[N:29][N:28]=2)[CH2:26][CH2:25]1참가 물질
3
실험 절차
The title compound, white solid, m.p. 246-248° C. and MS: m/e=333.1 (M+H+) was prepared in accordance with the general method of example 48a from (3,5-dimethylpyrazol-1-yl)-(9H-xanthen-9-yl)-methanone and 5-cyclopropyl-[1,3,4]oxadiazol-2-ylamine [J.Med.Pharm.Chem. 5, 617(1962)].
출처 및 근거
- ORD 기록
- ord-2e4f6cc2b6844a0fbb502f7be9d79fe6
- 출처 데이터셋
- uspto-grants-2003_07
- 특허 번호
- US06596743B2
연결된 노트
불러오는 중…